Patent Term Application for SYMVESS (acellular tissue engineered vessel-tyod), Patent No. 9,657,265 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2025-E-0862

Patent Term Application for SYMVESS (acellular tissue engineered vessel-tyod), Patent No. 9,657,265

Documents

Comments

Description

OPEN

Comment Period OpensMar 26, 2025

Comment Period ClosesApr 21, 2026

Type	Title	Posted	Comments	Status
Notice	Determination of Regulatory Review Period for Purposes of Patent Extension; SYMVESS FR Doc: 2026-03312	Feb 19, 2026	--

CDER

Patent Term Application for SYMVESS

Cooley LLP

Humacyte Global, Inc

Patent No. 9,657,265

(acellular tissue engineered vessel-tyod)

OPEN